These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10391649)

  • 1. Myocardial infarction.
    Bradley JP
    N Z Med J; 1999 May; 112(1088):191. PubMed ID: 10391649
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic therapy for acute myocardial infarction: where are we now? Where should we go?
    White HD
    Chin Med J (Engl); 1995 Jun; 108(6):462-5. PubMed ID: 7555259
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute myocardial infarction-failed thrombolysis followed by severe upper gastrointestinal bleeding.
    Remskar M; Mozina H; Noc M; Zorman D; Stepec S
    Resuscitation; 1999 Aug; 41(3):282-3. PubMed ID: 10507717
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development and results of thrombolytic therapy].
    Deutsch E; Ebringer H; Lechner K; Pilgerstorfer HW
    Wien Med Wochenschr; 1971 May; 121(20):410-5. PubMed ID: 5566996
    [No Abstract]   [Full Text] [Related]  

  • 7. [The characteristics of thrombolytic therapy in myocardial infarct in middle-aged and elderly patients].
    Teslia AN; Kolesnikov SA; Mikhaĭlov AA
    Voen Med Zh; 1999 Jul; 320(7):40-4. PubMed ID: 10484919
    [No Abstract]   [Full Text] [Related]  

  • 8. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
    Antman EM; Morrow DA; McCabe CH; Jiang F; White HD; Fox KA; Sharma D; Chew P; Braunwald E;
    Am Heart J; 2005 Feb; 149(2):217-26. PubMed ID: 15846258
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiplatelet and antithrombin therapy.
    Fernández-Ortiz A; Jang IK; Fuster V
    Coron Artery Dis; 1994 Apr; 5(4):297-305. PubMed ID: 8044341
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Acute MI. Institute for Clinical Systems Improvement.
    Postgrad Med; 1999 Nov; 106(6):57-8, 62-4, 74-6; passim. PubMed ID: 10576003
    [No Abstract]   [Full Text] [Related]  

  • 11. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.
    Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK
    Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unstable angina and non-Q-wave myocardial infarction. Treatment beyond aspirin and heparin.
    Theroux P
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):799. PubMed ID: 12497824
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of systemic thrombolytic therapy in acute myocardial infarct].
    Malaia LT; Dykun IaV; Kopitsa NP; Molodan VI
    Klin Med (Mosk); 1995; 73(4):42-4. PubMed ID: 7474817
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolytic therapy in acute myocardial infarction. Methodist Hospital experience.
    Pitts DE; Valentine RP; Brooks JA
    J Indiana State Med Assoc; 1983 Jun; 76(6):388-91. PubMed ID: 6875285
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction].
    Pereira H
    Rev Port Cardiol; 2000 Mar; 19(3):379-80. PubMed ID: 10804785
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombolytic therapy of acute myocardial infarct].
    De Giorgi E
    Minerva Cardioangiol; 1972 Nov; 20(11):663-6. PubMed ID: 4643520
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolytic therapy for myocardial infarction during menstruation.
    Darne RD; Singh S
    Can J Cardiol; 1998 Feb; 14(2):253-4. PubMed ID: 9520862
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracoronary thrombolytic (streptokinase) therapy of acute myocardial infarction in a community hospital; report of eleven consecutive cases.
    Mackie RW; Freeman DJ
    Wis Med J; 1983 Jan; 82(1):15-7. PubMed ID: 6829188
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute myocardial infarction: strategies for thrombolytic therapy.
    Fath-Ordoubadi F; Beatt KJ
    Br J Hosp Med; 1995 Jun 7-20; 53(11):575-80. PubMed ID: 7655756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.